Raxem Bio Tech Private Limited - Company Profile

It is a healthcare private limited company based in Coimbatore, Tamil Nadu, India, established in 2018.

2018 Coimbatore, Tamil Nadu, India Active

Last Updated: January 10, 2026

About Raxem Bio Tech Private Limited

Raxem Bio Tech Private Limited, a active private limited company, was established on 15 January 2018 in Coimbatore, Tamil Nadu, India. Engaging in medical appliances and instruments within the healthcare sector, it holds CIN: U33100TZ2018PTC029909. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Chakkukumarath Narayanan Subash Chandran (Director), Kurup Nalinakshan (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No:11, Peumal Konar Street Edayarpalayam, Coimbatore, Tamil Nadu, 641008.

Company Details

CIN/LLPIN
U33100TZ2018PTC029909
Registration Number
029909
Incorporation Date
15 January 2018
Authorized Capital
₹0.10 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Coimbatore
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.10 M as on 10-01-2026
Paid Up Capital ₹ 0.10 M as on 10-01-2026
Company Age 8 Year, 22 Days
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 133.01% (FY 2020)
Profit Growth **** 91.14% (FY 2020)
Ebitda **** 318.05% (FY 2020)
Net Worth 135.28% (FY 2020)
Total Assets -9.34% (FY 2020)

Comprehensive Company Insights

Explore comprehensive insights into Raxem Bio Tech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Raxem Bio Tech Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Chakkukumarath Narayanan Subash Chandran	Director	15 Jan 2018	Current
Kurup Nalinakshan	Director	15 Jan 2018	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Raxem Bio Tech.

Raxem Bio Tech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 133.01% increase. The company also saw a substantial improvement in profitability, with a 91.14% increase in profit. The company's net worth Soared by an impressive increase of 135.28%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

133.01%

*******

Revenue from Operations

*******

133.01%

*******

Total Assets

*******

-9.34%

*******

Profit or Loss

*******

91.14%

*******

Net Worth

*******

135.28%

*******

EBITDA

*******

318.05%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Raxem Bio Tech?

Unlock access to Raxem Bio Tech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Raxem Bio Tech?

Unlock and access historical data on people associated with Raxem Bio Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Raxem Bio Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raxem Bio Tech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Raxem Bio Tech

Recent Activity within the Organization

Annual General Meeting

The activity Raxem Bio Tech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Balance Sheet

Progress on Raxem Bio Tech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Coimbatore. was documented.
31 Mar 2025
Director Appointment

Chakkukumarath Narayanan Subash Chandran was appointed as a Director was appointed as a Director on 15 Jan 2018 & has been associated with this company since 8 years 22 days . was recorded as a recent event.
15 Jan 2018
Director Appointment

Progress on Kurup Nalinakshan was appointed as a Director was appointed as a Director on 15 Jan 2018 & has been associated with this company since 8 years 22 days . was documented.
15 Jan 2018
Company Incorporation

The activity Raxem Bio Tech Private Limited was registered on 15 Jan 2018 with Roc Coimbatore & aged 8 years 22 days as per MCA records. was completed.
15 Jan 2018

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Raxem Bio Tech Private Limited?

The CIN of Raxem Bio Tech Private Limited is U33100TZ2018PTC029909.

Where is Raxem Bio Tech Private Limited headquartered?

Raxem Bio Tech Private Limited is headquartered at No:11, Peumal Konar Street Edayarpalayam, Coimbatore, Tamil Nadu, 641008.

When was Raxem Bio Tech Private Limited incorporated?

Raxem Bio Tech Private Limited was incorporated on 15 January 2018.

Who are the current directors of Raxem Bio Tech Private Limited?

The current directors of Raxem Bio Tech Private Limited are

What is the primary industry of Raxem Bio Tech Private Limited?

The primary industry of Raxem Bio Tech Private Limited is Healthcare.

Is Raxem Bio Tech Private Limited a listed company?

Raxem Bio Tech Private Limited is unlisted.

What is the capital structure of Raxem Bio Tech Private Limited?

The authorized capital of Raxem Bio Tech Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available